Philips Faces Continued FDA Scrutiny Amidst Ongoing Product Recall
The U.S. Food and Drug Administration (FDA) has expressed continued dissatisfaction with the way Dutch healthcare technology firm Philips (PHG.AS) has managed a significant product recall and is urging the company to conduct additional risk assessments. As a result of...